Impact of post-stroke depression on the prognosis of stroke-associated pneumonia and analysis of predictive factors: A retrospective study of 186 patients

Table 3 Treatment modalities and prognostic outcomes, mean ± SD or n (%)

Outcome measure	Depression group (n = 92)	Non-depression group (n = 94)	P value
Treatment
Antibiotics duration (days)	14.2 ± 4.5	10.5 ± 3.2	< 0.001
Corticosteroid use	28 (30.4)	18 (19.1)	0.072
Warm moxibustion	35 (38.0)	43 (45.7)	0.291
Early enteral nutrition	55 (59.8)	68 (72.3)	0.068
Antidepressant treatment	45 (48.9)	-	-
Prognostic outcomes
Infection resolution (days)	16.8 ± 4.5	11.2 ± 3.2	< 0.001
Hospital stays (days)	28.5 ± 7.8	19.3 ± 5.6	< 0.001
28-day mortality	17 (18.5)	7 (7.4)	0.024
mRS ≥ 3 at discharge	67 (72.8)	46 (48.9)	0.001
mRS ≥ 4 at discharge	42 (45.7)	22 (23.4)	0.001
Barthel Index at discharge	48.2 ± 18.5	65.8 ± 14.2	< 0.001
Readmission within 30 days	22 (23.9)	10 (10.6)	0.015
Composite adverse outcome	52 (56.5)	26 (27.7)	< 0.001

Composite adverse outcome defined as 28-day mortality, infection resolution >21 days, mechanical ventilation >14 days, or modified Rankin Scale ≥ 4 at discharge. mRS: Modified Rankin Scale.